Why Enroll in this Course?
Lead Antimicrobial Stewardship, Save Lives, and Protect Global Health: Elevate Your Expertise in Infectious Disease Pharmacotherapy and Achieve BCIDP Certification.
Overview
Overview
Infectious Disease Pharmacy Review Course
Welcome to the Infectious Disease Pharmacy Review Course (BCIDP)
- Unlock your potential and embark on a journey to excellence in infectious disease pharmacotherapy with our comprehensive Infectious Disease Pharmacy Review Course (BCIDP).
- Designed for pharmacy professionals aiming to advance their expertise or prepare for the Board of Pharmacy Specialties (BPS) Infectious Diseases Pharmacy Specialty Certification Examination.
- This course will offer a preparatory review to BCIDP And helping you to becoming a Board-Certified Infectious Diseases Pharmacist (BCIDP).
Why Join This Course?
- Our course is prepared on the highest standards of educational excellence, drawing inspiration from American Board of Pharmacy Speciality (BPS).
- It’s meticulously designed to cover all aspects of infectious disease pharmacotherapy, aligning with the domains, tasks, and knowledge statements outlined in the BPS Infectious Diseases Pharmacy content outline.
By joining our course, you will:
- – Gain a deep understanding of microbiology, antimicrobial pharmacology, and the impact of infectious diseases.
- – Learn through case-based presentations, reflecting real-life scenarios, enhancing your decision-making and patient care skills.
- – Benefit from a comprehensive review of disease states, therapeutics, and the latest in antimicrobial stewardship, preparing you for the BPS certification exam with confidence.
- – Access a wealth of resources including practice exams, correct answers, links to reference sources, and more, all designed to ensure a robust learning experience.
- – Earn continuing pharmacy education and recertification credits, staying at the forefront of your field.
Course Chapters Include:
Infectious Disease Pharmacy Review Course Chapter Details
- Antimicrobial Stewardship: Overview and importance in healthcare settings.
- Microbiology: Introduction to bacteriology, virology, mycology, and parasitology.
- Antimicrobial Pharmacology – Part 1: Classes of antibiotics, antiviral, and antifungal agents.
- Antimicrobial Pharmacology – Part 2: Antiparasitic agents and emerging therapies.
- Pharmacokinetics and Pharmacodynamics (PK/PD): Basics and application in antimicrobial therapy.
- Upper Respiratory Tract Infections: Management of common bacterial and viral causes.
- Lower Respiratory Tract Infections: Pneumonia, bronchitis, and bronchiolitis management.
- Urinary Tract Infections: Strategies for uncomplicated and complicated UTIs.
- Bloodstream Infections: Bacteremia, sepsis, endocarditis, and catheter-related infections.
- Skin and Soft Tissue Infections: Classification, management, and surgical considerations.
- Sepsis: Early recognition, management guidelines, and protocols.
- Fungal Infections: Invasive candidiasis, aspergillosis, and other fungal pathogens.
- Preventive Therapies (Vaccines): Role of vaccines in preventing infections.
- Surgical Prophylaxis: Guidelines and antimicrobial selection.
- Antimicrobial Stewardship Strategies: Advanced interventions and stewardship in special settings.
- Metrics for Evaluating Antimicrobial Stewardship: Outcome and process measures, benchmarking.
- Infection Prevention and Antibiogram: Control measures and antibiogram utilization.
- Clinical Practice Guidelines: Development, use, and critical appraisal.
- Patient and Caregiver Education and Counseling Techniques: Effective communication and adherence strategies.
- Optimize an Infectious Diseases Pharmacotherapeutic and/or Monitoring Plan: Therapeutic drug monitoring and adjustment.
- Metrics for Evaluating Stewardship Challenge, Service, and Cost: Financial impact and quality indicators.
- Outpatient Parenteral Antimicrobial Therapy (OPAT): Program design and safety monitoring.
- Medication Management and Use: Safe prescription practices and medication reconciliation.
- Pharmacoeconomic Assessments: Cost-effectiveness and budget impact analyses.
- Statistical Methods and Interpretation: Basics of biostatistics and clinical trial data interpretation.
- Study Design: Overview of study types and critical appraisal skills.
Importance of This Course:
- In the ever-evolving field of pharmacy, specializing in infectious diseases pharmacotherapy is not just a career advancement opportunity but a necessity to combat the global challenge of infectious diseases and antimicrobial resistance (AMR).
- This course empowers you to develop, implement, and monitor effective antimicrobial therapies, lead antimicrobial stewardship programs, and contribute significantly to public health.
Your Path to Certification:
- Becoming a BCIDP or Board-Certified Infectious Disease Specialized Pharmacist that you possess the advanced knowledge and experience necessary to optimize antimicrobial therapy, provide direct patient care, and lead in the field of infectious diseases pharmacy.
- Our course is structured to guide you through the examination curriculum, ensuring you are well-prepared to meet and exceed the standards set by the Board of Pharmacy Specialties.
- Join us today and take the first step towards distinguishing yourself as an expert in infectious diseases pharmacy.
- With our course, you’re not just preparing for an exam; you’re preparing to make a difference in the lives of patients and the broader public health landscape.
With FADIC Infectious Disease Pharmacy Review Course (BCIDP)
- “Lead Antimicrobial Stewardship, Save Lives, and Protect Global Health: Elevate Your Expertise in Infectious Disease Pharmacotherapy and Achieve BCIDP Certification.”
If you have any inquiry, please contact WhatsApp.
Curriculum
-
1- Antimicrobial stewardship
- Clinical Quotes from Alexander Fleming Nobel Prize Lecture
- Welcome to Antimicrobial Stewardship School
- UK Report for 2050 Mortality of Antimicrobial Resistance
- History of Antimicrobial Stewardship
- Goals of Antimicrobial Stewardship
- Systematic Thinking in Potentially Infected Patients
- Antimicrobial Stewardship Algorithms
- FADIC Descriptive Study in Antimicrobial Stewardship Program
-
2- Microbiology
- Microbiology Introduction
- Gram-Positive Vs. Gram-Negative Bacteria
- Minimum Inhibitory Concentration Interpretation (MIC)
- Anaerobes Organisms
- Summarized Bacterial Types
- Microbiology Resources
- Staphylococcus
- Streptococcus
- Haemophilus Influenzae, Neisseria Meningitidis
- E. coli
-
3- Antimicrobial Pharmacology – Part 1
- Clinical Pharmacology of the Penicillin
- Beta lactams: Penicillin
- Penicillin and the Cell Wall
- Penicillin Allergy
- Case Scenario
- Cephalosporins Classification
- Meropenem, Imipenem
- Vancomycin
- Telavancin, Dalbavancin, and Oritavancin
- Polymyxin PK and Case Scenario
-
4- Antimicrobial Pharmacology – Part 2
- Clindamycin
- Chloramphenicol
- Ciprofloxacin, Levofloxacin and Moxifloxacin
- Fluoroquinolones Safety Alerts
- Metronidazole
- Sulfamethoxazole Trimethoprim
- Nitrofurantoin and Fidaxomicin
- Fosfomycin
- Antimicrobials for Animals
- Tedizolid
-
5- Pharmacokinetics and Pharmacodynamics
- Pharmacokinetics Basics
- Absorption, Distribution, Metabolism, and Elimination (ADME) of Antimicrobials
- Therapeutic Drug Monitoring
- The Role of Pharmacokinetics and Antimicrobial Stewardship
- Pharmacokinetics Mobile Applications
- Understanding the pharmacodynamics of antimicrobials
- Pharmacodynamics Basic Definitions
- Application of Antimicrobial Pharmacodynamics
- Bacterial resistance and pharmacodynamics
- Antimicrobial Stewardship and Pharmacodynamics
-
6- Upper respiratory tract Infections
- Upper Respiratory Tract Infection (URTI)
-
7- Lower Respiratory Tract Infections
- Hospital and Ventilator-acquired pneumonia
- Community-acquired pneumonia
-
8- Urinary Tract Infections
- The Pathogenesis of Urinary Tract Infections
- Acute Pyelonephritis
- Acute cystitis
-
9- Bloodstream Infections
- Catheter Related Bloodstream Infection
-
10- Skin and Soft Tissue Infections
- SSTI (Impetigo, Erysipelas, and Cellulitis)
- SSTI (Necrotizing fasciitis, and Diabetic foot infection)
- Antimicrobial Stewardship in SSTI
-
11- Sepsis
- OLD Versus NEW Sepsis Definitions
- Comparison of SIRS, SOFA & qSOFA
- Antibiotic Stewardship in Sepsis Management
-
12- Fungal infections
- All About Antifungals From Guidelines to Bedside
- Management of Invasive Candidiasis
- Anti-fungal Pharmacokinetics and Pharmacodynamics
- Clinical Pharmacology of Anti-Fungi
- Antimicrobial Stewardship Workshop
-
13- Preventive Therapies (Vaccines)
- Active Vs Passive Immunity | Vaccines
-
14- Surgical Prophylaxis
- Antimicrobial Prophylaxis & Surgical Site Infection
-
15- Antimicrobial Stewardship Strategies
- Antimicrobial Stewardship Core Strategies
- Antibiogram, De-escalation & Formulary Restriction
- IV to Oral, Prospective Audit & Antibiotic Time-Out
- Antimicrobial Stewardship Intervention Sheet
- Antimicrobial Stewardship Workshop
-
16- Metrics for Evaluating Antimicrobial Stewardship
- Webinar 2
- Clinical Outcomes of Stewardship
- Resistance Outcome
- Economic Outcomes of Stewardship
- Prioritization “Low-Hanging Fruit”
- Antimicrobial Stewardship Workshop
-
17- Infection prevention and Antibiogram
- The P&T Committee and Antimicrobial Stewardship Subcommittee: Pivotal Roles for AMS Pharmacists
-
18- Clinical Practice Guidelines
- How to Write the Antibiotic Policy & Guidelines ?
-
19- Patient and caregiver education and counseling techniques
- Selection of Antimicrobial Drugs
- Penicillin Allergy & Counseling
- Cephalosporin Counseling
- Tetracycline
- Tigecycline
- Macrolides
- Metronidazole
- Sulfamethoxazole/Trimethoprim
- Sulfonamide
- The Most Common Antibiotics are Used in Prescriptions
-
20- Optimize an infectious diseases pharmacotherapeutic and/or monitoring plan
- Webinar 1
-
21- Metrics for evaluating stewardship challenge, service, and cost
- Clinical Outcomes of Stewardship
- Resistance Outcome
- Economic Outcomes of Stewardship
- Prioritization “Low-Hanging Fruit”
-
22- Outpatient Parenteral Antimicrobial Therapy (OPAT)
- FADIC Outpatient Antimicrobial Therapy Book
-
23- Medication Management and Use
- Medication Management and Use
-
24- Pharmacoeconomic Assessments
- The Importance of Pharmacoeconomics
- Cost-Utility Analysis
- Cost-Effectiveness Analysis
- Cost-Benefit Analysis
- Cost-Minimization Analysis
- Pharmacoeconomic Role of Pharmacists
- Application of Clinical Pharmacoeconomics
- Pharmacoepidemiology definition
- Primary Vs. Secondary Data Collection Sources
- Pharmacoepidemiology in Pharmacy Practice
-
25- Statistical Methods and Interpretation
- Introduction to Statistics
- Basics of Biostatistics
- Clinical Application of Biostatistics
-
26- Study Design
- Introduction of Clinical Trial
- Phases of Clinical Trials
- Controlled Clinical Trial Evaluation
-
27- Evidence-Based Medicine and Research Design
- Introduction of EBM
- Evidence-Based Practice learning Series: Ask, Acquire, and Appraise
- Evidence-Based Practice learning Series: Apply, and Assess
-
28- Critically Evaluate ID Literature
- Literature search databases
- Critical Appraisal of Systematic Review
- Example of Systematic Review Appraisal
-
29- Process Improvement Tools
- Root Cause Analysis VS FMEA
- What is the Change Management & Benefits?
- Values & Principles of Change Management
- John Kotter 8-Step Change Model
- Diffusion of Innovation & Change Spread
- The 5 Stages of Innovation-Decision Process
- Six Sigma – Lean – Kaizen Model
- TeamSTEPPS- Team Strategies and Tools to Enhance
- Common Pitfalls Encountered When Leading Change
- Create & Integrate Medication Safety Strategic Plan
-
30- Central Nervous System Infections
- Meningitis
-
31- HIV Infection and AIDS
- Human Immunodeficiency Virus
- Pneumocystis jiroveci Pneumonia
- Disseminated Mycobacterium avium Complex
- Cryptococcal meningitis
- Toxoplasma Gondii Encephalitis
- Tuberculosis in HIV
- HIV-Related Immunisations Pre and Post
-
32- Sexually Transmitted Diseases
- Sexually Transmitted Diseases
- Gonorrhoea
- Chlamydia
- Cervicitis
- Nongonococcal Urethritis
- Syphilis
- Genital Herpes
- Genital Warts
- Trichomoniasis
- Pelvic Inflammatory Disease
-
33- Tuberculosis and Other Mycobacterial Infections
- Active Tuberculosis
- HIV_Tuberculosis (TB) Coinfection
- Latent Tuberculosis Infection
- Summary of Medications for Active Tuberculosis
- Multidrug-Resistant Tuberculosis
-
34- Cardiovascular Infections
- Infective Endocarditis
Features
1060 USD
370 USD
Enroll Now